PetDx’s Post

NationWide Laboratories now receives samples for Nu.Q® Vet Cancer Test. For more details and to use this service email [email protected] or visit our website https://lnkd.in/eiHHEvdB Veterinary Cancer Society estimates that one in four dogs will be diagnosed with cancer in their lifetime. Early detection, same as with humans, is key for better outcomes in these dogs. Nu.Q® Vet Cancer Test by Volition Veterinary is a non-invasive, affordable, easy-to-use blood test for cancer screening which can be done as part of our wellness and preventative care packages. Nu.Q® Vet Cancer Test can detect cancers such as lymphoma and hemangiosarcoma, even at early stages. Preliminary data suggests that this screening test can also detect some instances of Mast Cell tumours, malignant melanomas and Histiocytic Sarcoma. This screening test along with a standard regular preventative blood work and imaging will enable you to give dog owners a clear picture of their dog’s health at the time of testing and help define the healthcare options. #veterinary #laboratory #dogs #cancer #sample #vetnurse #vetsurgeon

🐾 New Study Saturday 🐾 Researchers at University of Pennsylvania School of Veterinary Medicine, funded by the CHF, are revolutionizing the fight against canine cancer. They're engineering white blood cells to target TWO antigens on cancer cells, aiming to kill those cancer cells and outsmart cancer's resistance to treatment. This could be a game-changer in immunotherapy for our dogs! Learn more about this hopeful advance at https://bit.ly/439NBi3 #Immunotherapy #Lymphoma #CanineHealthResearch #OneHealth #NewStudySaturday

Dr. Skylar Sylvester, assistant clinical professor of medical oncology at #CornellVet, writes that "cancer is the leading cause of death in older dogs, yet there is no consensus among veterinarians regarding cancer screening or diagnostic guidelines." Liquid biopsy has emerged as a powerful, multifaceted tool for cancer detection and multi-cancer early detection (MCED) tests are now commercially available for dogs, but "before we can broadly incorporate these tests into our clinical practice, we need to understand how they work, consider the evidence behind them, and demonstrate that using them reduces cancer-related deaths, predicts prognosis, or prolongs dogs’ lives with cancer to a clinically significant degree." Read more via Veterinary Practice News: https://lnkd.in/eb8Tevbk

So much to learn from Dr. Chand Khanna from his current research on hemangiosarcoma and how the results are looking better than expected, to his approach to cancer patients and communication with pet owners. This is a must listen to episode

🐶🐶🐶A New Canine Study from NC State University🐶🐶🐶 Did you know that "normal" white blood cells lose the Y chromosome as men age (happening in over 40% of men in their 70s)? This phenomenon, known as the loss of the Y chromosome (LOY), was once thought to be a random and benign genomic event. However, recent studies have shown that LOY is linked to increased risks of many common health conditions, including heart disease, cancer, neurodegenerative diseases, and overall mortality. LOY is also prevalent in various human male cancers, likely aiding the growth of cancer cells. Given these insights, my research focused on determining whether this phenomenon occurs in dogs, as in humans, especially as dogs live much longer today due to improved veterinary care. We investigated LOY in non-neoplastic leukocytes and in various hematopoietic cancers of male dogs. Key Findings: Unlike humans, dogs do not develop LOY in non-neoplastic leukocytes—a piece of good news for our furry friends, I believe. Similar to humans, canine hematopoietic cancers exhibit LOY at variable frequencies. The more aggressive the lymphoma or leukemia, the more likely it is to lose the Y chromosome, though it appears rare or absent in indolent hematopoietic cancers. These results were recently published in the Veterinary Journal and are available here: https://lnkd.in/eNWAYDDY. Following the observation of LOY in aggressive hematopoietic cancers in dogs, we are planning a follow-up study to explore the biological and clinical implications of this genomic event. I hope our study sheds light on this intriguing genomic phenomenon in both humans and dogs, ultimately contributing to advancements in veterinary and human medicine.

📢 Starting in less than 30 minutes! The immune system represents a novel therapy in the treatment of cancer in both physician-based and veterinary oncology. This lecture will discuss the basics behind immunotherapy and highlight many of the current immunotherapies available to veterinary clinicians. Specifically, we will discuss the Oncept Melanoma vaccine, Elias Animal Health Immunotherapy (ECI® ), and Merk's PD-1 monoclonal antibody (GilvetmabI® ). We will focus on the data and where these products will be utilized as part of our arsenal in the battle against cancer. https://lnkd.in/gCh3H3DB

🚨 Watch On-Demand: Transforming Canine Cancer Care Webinar! 🚨 Missed the live event? No problem! You can now watch the on-demand webinar sponsored by CanCan Diagnostics Ltd, "Transforming Canine Cancer Care: Early Relapse Detection and Disease Monitoring with Cutting-Edge Liquid Biopsy Technology." 🔍 What You’ll Learn: -Innovative liquid biopsy technology for canine cancer care -Early relapse detection techniques -Advanced methods for disease monitoring Enhance your knowledge and skills in veterinary oncology with this insightful session! 🎥 Watch Now via the link in the comments. #VeterinaryWebinar #CanineCancerCare #LiquidBiopsy #VetOncology #VeterinaryMedicine #OnDemandWebinar

Outcome of hypercalcemia of malignancy and concurrent azotemia in dogs with lymphoma Hypercalcemia of malignancy (HM) secondary to lymphoma in dogs has the potential to cause renal injury. The primary aim of this retrospective study was to characterize outcomes related to acute kidney injury (AKI) secondary to HM. The authors hypothesized that dogs do suffer AKI regardless of HM severity at the time of lymphoma diagnosis or relapse. Read more: https://lnkd.in/gcHgd65M #veterinary33 #veterinaryjournal #veterinaryarticle #alwayslearning #scientificjournals #journals #scientificarticles #articles

【Clinicopathological Description of a Chronic Lymphocytic Leukemia in a Dog】 Full article: https://lnkd.in/gM4WepB8 (Authored by Maria Clara Boni Raffi, et al., from São Paulo State University—UNESP (Brazil), etc.) #Canine hematopoietic neoplasms are a common diagnosis in clinical veterinary practice. However, hematopoietic tumors are associated with diagnostic and therapeutic challenges and their pathophysiology in dogs is not well understood. This paper reports a case of chronic lymphocytic leukemia in a female dog with clinical, laboratory, and necroscopy findings, and highlights the clinical and diagnostic complexities encountered with the neoplasm. #Cancer #Therapeutics

As new research continues to improve the care of humans who develop #cancer, Dr. David Vail is among those who investigate how these discoveries can also help our furry friends. Cancer is the number one cause of death for adult #dogs and #cats, according to Vail, a veterinary oncologist, UW Carbone Cancer Center researcher, and Barbara A. Suran Chair in Comparative Oncology at the University of Wisconsin School of Veterinary Medicine. Part of this increase is due to these companion animals living longer than in the past, as cancer risk rises with age. 'We see it all the time, and for some forms of cancer we don’t have a good standard of care,' Vail said. 'I mean, at the end of the day I’m a veterinarian, and so I want to help my patients as well.' Comparative #oncology seeks to investigate cancer diagnostics, treatments and #prevention in all species in hopes that new technologies and treatments can be developed faster and translated into both the veterinary care of companion animals as well as preliminary data that can inform human #clinicaltrials. 'This comparative approach is truly a bidirectional approach, and everybody has the potential to win,' Vail said. 'This whole approach brings many, many super-talented people together to try and solve this common underlying problem of a hundred different diseases that we call cancer.' Article: 'Cancer research helps humans and pets' https://lnkd.in/geSCV63b via UW Health Note: If you would like to learn more from Dr. Vail directly, please register for our #webinar on 3/6: https://lnkd.in/dKes_XcZ #university #Wisconsin #veterinarymedicine #clinicalresearch